Physician profile
Tapan A Padhya
NPI 1740215318
$22,207.05
in general payments reported to CMS, 2019-2025
13 companies · $6,988 in 2025
The $6,988 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,866 · 2020: $187 · 2021: $8,506 · 2022: $743 · 2023: $408 · 2024: $3,509 · 2025: $6,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,588 · Honoraria: $2,000 · Travel and Lodging: $1,195 · Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,587.50 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $1,194.88 |
| Food and Beverage | $1,122.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $11,725.15 | 2019-2025 | Inspire |
| Intuitive Surgical, INC. | $7,595.99 | 2021 | |
| Verathon INC. | $1,600.00 | 2024 | Video Laryngoscope |
| Depuy Synthes Sales INC. | $698.52 | 2021-2024 | Trumatch, Na, Matrixmandible |
| Medtronic USA, INC. | $145.99 | 2020 | |
| Medical Device Business Services, INC. | $123.03 | 2021 | |
| Philips North America LLC | $74.42 | 2019 | |
| Karl Storz Endoscopy-America | $72.74 | 2021-2022 | |
| Kls-Martin L.P. | $41.45 | 2020 | |
| Medtronic, INC. | $37.03 | 2022-2024 | Signia |
| Ethicon US, LLC | $36.96 | 2021 | |
| Ambu INC. | $33.99 | 2023 | |
| Smith+Nephew, INC. | $21.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tapan Padhya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.